Overcoming the Barriers to Patient Access in 2024 and Beyond
Patient access barriers in 2024 are increasingly complex, driven by regulatory changes, payer restrictions, and evolving treatment landscapes. In this BioPharma Dive webinar, MMIT’s Dinesh Kabaleeswaran and Dedham Group’s Jen Klarer discuss insights from the 2024 State of Patient Access Survey, highlight challenges in cell and gene therapy, and explain how investments in real-world data (RWD) and AI are helping pharma organizations optimize market access strategies.
Understand pharma’s response to the IRA and other regulatory changes.
Find the barriers hindering patient access in areas of clinical advancement.
Hear how investments in real-world data and AI will change market access planning.